Page last updated: 2024-10-17

coumarin and Thrombopenia

coumarin has been researched along with Thrombopenia in 13 studies

2H-chromen-2-one: coumarin derivative

Research Excerpts

ExcerptRelevanceReference
"A severe thrombotic thrombocytopenic status, induced by heparin in a sixty-nine-year-old woman undergoing total hip joint arthroplasty, was treated by switching the anticoagulant therapy to coumarin, which induced skin necrosis."7.69Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report. ( Boda, Z; Pósán, E; Rigó, J; Shahak, A; Szücs, G, 1996)
"A patient with evidence of both heparin-related thrombocytopenia and coumarin-induced skin necrosis is presented."7.67Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report. ( Banson, B; Berman, JA; Celoria, GM; Friedmann, P; Rhee, SW; Steingart, RH, 1988)
"Significant advances in the pharmacological prophylaxis of venous thromboembolism have occurred since warfarin and unfractionated heparin were introduced for this indication nearly 60 years ago."4.82Current options in the prevention of thromboembolic disease. ( Ansell, J; Bergqvist, D, 2004)
" Introduction of coumarin therapy for venous thromboembolism should be started on day 1 of diagnosis, keeping the total duration of heparin therapy at no more than five days and therefore minimizing the incidence of heparin-induced thrombocytopenia."3.72[Anticoagulation in patients with venous thromboembolism]. ( Rüfer, A; Wuillemin, WA, 2003)
"A severe thrombotic thrombocytopenic status, induced by heparin in a sixty-nine-year-old woman undergoing total hip joint arthroplasty, was treated by switching the anticoagulant therapy to coumarin, which induced skin necrosis."3.69Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report. ( Boda, Z; Pósán, E; Rigó, J; Shahak, A; Szücs, G, 1996)
"A patient with evidence of both heparin-related thrombocytopenia and coumarin-induced skin necrosis is presented."3.67Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report. ( Banson, B; Berman, JA; Celoria, GM; Friedmann, P; Rhee, SW; Steingart, RH, 1988)
" Because of their completely different chemical structure, hirudins are a safe alternative for anticoagulation."2.46The complex clinical picture of side effects to anticoagulation. ( Seitz, CS; Trautmann, A, 2010)
" Post-marketing experience suggests that standard dosing of lepirudin is too high; current recommendations are to avoid the initial lepirudin bolus and to begin with lower infusion rates, even in patients without overt renal dysfunction."2.43Think of HIT. ( Warkentin, TE, 2006)
" The guidelines include specific recommendations for nonheparin anticoagulant dosing that differ from the package inserts."1.35Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). ( Greinacher, A; Koster, A; Lincoff, AM; Warkentin, TE, 2008)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's2 (15.38)18.2507
2000's7 (53.85)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Warkentin, TE5
Greinacher, A2
Koster, A1
Lincoff, AM1
Trautmann, A1
Seitz, CS1
Olah, Z1
Bereczky, Z1
Szarvas, M1
Boda, Z2
Rüfer, A1
Wuillemin, WA1
MOREO, GC1
GIBELLI, A1
Ansell, J1
Bergqvist, D1
Lubenow, N1
Wessel, A1
Sloane, DA1
Krahn, EL1
Magnani, HN1
Shahak, A1
Pósán, E1
Szücs, G1
Rigó, J1
Levine, MN1
Anderson, DR1
Celoria, GM1
Steingart, RH1
Banson, B1
Friedmann, P1
Rhee, SW1
Berman, JA1

Reviews

5 reviews available for coumarin and Thrombopenia

ArticleYear
The complex clinical picture of side effects to anticoagulation.
    The Medical clinics of North America, 2010, Volume: 94, Issue:4

    Topics: Anaphylaxis; Anticoagulants; Coumarins; Drug Eruptions; Fibrinolytic Agents; Fondaparinux; Heparin;

2010
An overview of the heparin-induced thrombocytopenia syndrome.
    Seminars in thrombosis and hemostasis, 2004, Volume: 30, Issue:3

    Topics: Antibodies; Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Heparitin Sulfate; Humans;

2004
Current options in the prevention of thromboembolic disease.
    Drugs, 2004, Volume: 64 Suppl 1

    Topics: Administration, Oral; Anticoagulants; Coumarins; Fondaparinux; Heparin; Humans; Injections, Subcutan

2004
Think of HIT.
    Hematology. American Society of Hematology. Education Program, 2006

    Topics: Contraindications; Coumarins; Heparin; Humans; Practice Guidelines as Topic; Thrombin; Thrombocytope

2006
Side-effects of antithrombotic therapy.
    Bailliere's clinical haematology, 1990, Volume: 3, Issue:3

    Topics: Administration, Oral; Adult; Animals; Anticoagulants; Coumarins; Drug Eruptions; Drug Hypersensitivi

1990

Trials

1 trial available for coumarin and Thrombopenia

ArticleYear
Side-effects of antithrombotic therapy.
    Bailliere's clinical haematology, 1990, Volume: 3, Issue:3

    Topics: Administration, Oral; Adult; Animals; Anticoagulants; Coumarins; Drug Eruptions; Drug Hypersensitivi

1990

Other Studies

8 other studies available for coumarin and Thrombopenia

ArticleYear
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Chest, 2008, Volume: 133, Issue:6 Suppl

    Topics: Coumarins; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Platelet Count; Thrombocyt

2008
Coagulation: cascade!
    Lancet (London, England), 2011, Aug-20, Volume: 378, Issue:9792

    Topics: Aged; Anticoagulants; Coumarins; Enoxaparin; Gangrene; Heparin; Humans; International Normalized Rat

2011
[Anticoagulation in patients with venous thromboembolism].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1

    Topics: Anticoagulants; Bandages; Clinical Trials as Topic; Coumarins; Fibrinolytic Agents; Heparin; Heparin

2003
[CAPILLARY-PROTECTIVE ACTION OF 4-METHYL-6,7-(BIS-BETA-DIETHYLAMINOETHOXY)-COUMARIN HYROCHLORIDE IN PARENTERAL AND ORAL ADMINISTRATION. STUDY OF BLEEDING TIME AND INTENSITY AND PETECHIOMETRY].
    Haematologica, 1963, Volume: 48

    Topics: Administration, Oral; Bleeding Time; Capillaries; Coumarins; Hepatitis; Humans; Pharmacology; Purpur

1963
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
    Thrombosis research, 2006, Volume: 117, Issue:5

    Topics: Aged; Ancrod; Canada; Chondroitin Sulfates; Cohort Studies; Coumarins; Dermatan Sulfate; Female; Ger

2006
Should vitamin K be administered when HIT is diagnosed after administration of coumarin?
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:4

    Topics: Aged, 80 and over; Anticoagulants; Cardiac Surgical Procedures; Coumarins; Extremities; Gangrene; He

2006
Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report.
    Angiology, 1996, Volume: 47, Issue:7

    Topics: Aged; Anticoagulants; Coumarins; Female; Heparin; Hip Prosthesis; Humans; Necrosis; Postoperative Co

1996
Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report.
    Angiology, 1988, Volume: 39, Issue:10

    Topics: Aorta; Aorta, Thoracic; Coumarins; Female; Femoral Artery; Heparin; Humans; Intermittent Claudicatio

1988